Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations

Judit Herédi, Edina Katalin Cseh, A. Berkó, G. Veres, Dénes Zádori, J. Toldi, Z. Kis, L. Vécsei, Etsuro Ono, Levente Gellért

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Manipulation of kynurenic acid (KYNA) level through kynurenine aminotransferase-2 (KAT-2) inhibition with the aim of therapy in neuro-psychiatric diseses has been the subject of extensive recent research. Although mouse models are of particular importance, neither the basic mechanism of KYNA production and release nor the relevance of KAT-2 in the mouse brain has yet been clarified. Using acute mouse brain slice preparations, we investigated the basal and L-kynurenine (L-KYN) induced KYNA production and distribution between the extracellular and intracellular compartments. Furthermore, we evaluated the effect of specific KAT-2 inhibition with the irreversible inhibitor PF-04859989. To ascertain that the observed KYNA release is not a simple consequence of general cell degradation, we examined the structural and functional integrity of the brain tissue with biochemical, histological and electrophysiological tools. We did not find relevant change in the viability of the brain tissue after several hours incubation time. HPLC measurements proved that mouse brain slices intensively produce and liberate KYNA to the extracellular compartment, while only a small proportion retained in the tissue both in the basal and L-KYN supplemented state. Finally, specific KAT-2 inhibition significantly reduced the extracellular KYNA content. Taken together, these results provide important data about KYNA production and release, and in vitro evidence for the first time of the function of KAT-2 in the adult mouse brain. Our study extends investigations of KAT-2 manipulation to mice in a bid to fully understand the function; the final, future aim is to assign therapeutical kynurenergic manipulation strategies to humans.

Original languageEnglish
Pages (from-to)185-191
Number of pages7
JournalBrain Research Bulletin
Volume146
DOIs
Publication statusPublished - Mar 1 2019

Fingerprint

kynurenine-oxoglutarate transaminase
Kynurenic Acid
Brain
Kynurenine
Tissue Survival
Psychiatry
High Pressure Liquid Chromatography

Keywords

  • Acute slice viability
  • HPLC
  • Immunohistochemistry
  • In vitro electrophysiology
  • Kynurenic acid
  • Kynurenine aminotransferase-2 inhibition

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations. / Herédi, Judit; Cseh, Edina Katalin; Berkó, A.; Veres, G.; Zádori, Dénes; Toldi, J.; Kis, Z.; Vécsei, L.; Ono, Etsuro; Gellért, Levente.

In: Brain Research Bulletin, Vol. 146, 01.03.2019, p. 185-191.

Research output: Contribution to journalArticle

Herédi, Judit ; Cseh, Edina Katalin ; Berkó, A. ; Veres, G. ; Zádori, Dénes ; Toldi, J. ; Kis, Z. ; Vécsei, L. ; Ono, Etsuro ; Gellért, Levente. / Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations. In: Brain Research Bulletin. 2019 ; Vol. 146. pp. 185-191.
@article{b116ff68519e4f9c81f267b7fcae41fb,
title = "Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations",
abstract = "Manipulation of kynurenic acid (KYNA) level through kynurenine aminotransferase-2 (KAT-2) inhibition with the aim of therapy in neuro-psychiatric diseses has been the subject of extensive recent research. Although mouse models are of particular importance, neither the basic mechanism of KYNA production and release nor the relevance of KAT-2 in the mouse brain has yet been clarified. Using acute mouse brain slice preparations, we investigated the basal and L-kynurenine (L-KYN) induced KYNA production and distribution between the extracellular and intracellular compartments. Furthermore, we evaluated the effect of specific KAT-2 inhibition with the irreversible inhibitor PF-04859989. To ascertain that the observed KYNA release is not a simple consequence of general cell degradation, we examined the structural and functional integrity of the brain tissue with biochemical, histological and electrophysiological tools. We did not find relevant change in the viability of the brain tissue after several hours incubation time. HPLC measurements proved that mouse brain slices intensively produce and liberate KYNA to the extracellular compartment, while only a small proportion retained in the tissue both in the basal and L-KYN supplemented state. Finally, specific KAT-2 inhibition significantly reduced the extracellular KYNA content. Taken together, these results provide important data about KYNA production and release, and in vitro evidence for the first time of the function of KAT-2 in the adult mouse brain. Our study extends investigations of KAT-2 manipulation to mice in a bid to fully understand the function; the final, future aim is to assign therapeutical kynurenergic manipulation strategies to humans.",
keywords = "Acute slice viability, HPLC, Immunohistochemistry, In vitro electrophysiology, Kynurenic acid, Kynurenine aminotransferase-2 inhibition",
author = "Judit Her{\'e}di and Cseh, {Edina Katalin} and A. Berk{\'o} and G. Veres and D{\'e}nes Z{\'a}dori and J. Toldi and Z. Kis and L. V{\'e}csei and Etsuro Ono and Levente Gell{\'e}rt",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.brainresbull.2018.12.014",
language = "English",
volume = "146",
pages = "185--191",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Investigating KYNA production and kynurenergic manipulation on acute mouse brain slice preparations

AU - Herédi, Judit

AU - Cseh, Edina Katalin

AU - Berkó, A.

AU - Veres, G.

AU - Zádori, Dénes

AU - Toldi, J.

AU - Kis, Z.

AU - Vécsei, L.

AU - Ono, Etsuro

AU - Gellért, Levente

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Manipulation of kynurenic acid (KYNA) level through kynurenine aminotransferase-2 (KAT-2) inhibition with the aim of therapy in neuro-psychiatric diseses has been the subject of extensive recent research. Although mouse models are of particular importance, neither the basic mechanism of KYNA production and release nor the relevance of KAT-2 in the mouse brain has yet been clarified. Using acute mouse brain slice preparations, we investigated the basal and L-kynurenine (L-KYN) induced KYNA production and distribution between the extracellular and intracellular compartments. Furthermore, we evaluated the effect of specific KAT-2 inhibition with the irreversible inhibitor PF-04859989. To ascertain that the observed KYNA release is not a simple consequence of general cell degradation, we examined the structural and functional integrity of the brain tissue with biochemical, histological and electrophysiological tools. We did not find relevant change in the viability of the brain tissue after several hours incubation time. HPLC measurements proved that mouse brain slices intensively produce and liberate KYNA to the extracellular compartment, while only a small proportion retained in the tissue both in the basal and L-KYN supplemented state. Finally, specific KAT-2 inhibition significantly reduced the extracellular KYNA content. Taken together, these results provide important data about KYNA production and release, and in vitro evidence for the first time of the function of KAT-2 in the adult mouse brain. Our study extends investigations of KAT-2 manipulation to mice in a bid to fully understand the function; the final, future aim is to assign therapeutical kynurenergic manipulation strategies to humans.

AB - Manipulation of kynurenic acid (KYNA) level through kynurenine aminotransferase-2 (KAT-2) inhibition with the aim of therapy in neuro-psychiatric diseses has been the subject of extensive recent research. Although mouse models are of particular importance, neither the basic mechanism of KYNA production and release nor the relevance of KAT-2 in the mouse brain has yet been clarified. Using acute mouse brain slice preparations, we investigated the basal and L-kynurenine (L-KYN) induced KYNA production and distribution between the extracellular and intracellular compartments. Furthermore, we evaluated the effect of specific KAT-2 inhibition with the irreversible inhibitor PF-04859989. To ascertain that the observed KYNA release is not a simple consequence of general cell degradation, we examined the structural and functional integrity of the brain tissue with biochemical, histological and electrophysiological tools. We did not find relevant change in the viability of the brain tissue after several hours incubation time. HPLC measurements proved that mouse brain slices intensively produce and liberate KYNA to the extracellular compartment, while only a small proportion retained in the tissue both in the basal and L-KYN supplemented state. Finally, specific KAT-2 inhibition significantly reduced the extracellular KYNA content. Taken together, these results provide important data about KYNA production and release, and in vitro evidence for the first time of the function of KAT-2 in the adult mouse brain. Our study extends investigations of KAT-2 manipulation to mice in a bid to fully understand the function; the final, future aim is to assign therapeutical kynurenergic manipulation strategies to humans.

KW - Acute slice viability

KW - HPLC

KW - Immunohistochemistry

KW - In vitro electrophysiology

KW - Kynurenic acid

KW - Kynurenine aminotransferase-2 inhibition

UR - http://www.scopus.com/inward/record.url?scp=85059943409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059943409&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2018.12.014

DO - 10.1016/j.brainresbull.2018.12.014

M3 - Article

C2 - 30639278

AN - SCOPUS:85059943409

VL - 146

SP - 185

EP - 191

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

ER -